Worldwide Healthcare Trust


Market Cap£2152.9m

Last Close 3285p

Worldwide Healthcare Trust’s investment objective is to invest worldwide in pharmaceutical, biotechnology and related securities in the healthcare sector to achieve a high level of capital growth. Gearing and derivative transactions are used to mitigate risk and enhance capital returns.

More Worldwide Healthcare Trust content >

Investment summary

Worldwide Healthcare Trust (WWH) has two very experienced co-managers, Sven Borho and Trevor Polischuk at healthcare specialist investor OrbiMed. They remain very positive on the outlook for the healthcare sector due to favourable industry fundamentals and relatively attractive valuations. Despite a period of underperformance this year due to the outperformance of large-cap companies and a market rotation from growth to value stocks given increased confidence in a post-pandemic economic rebound, WWH retains a long-term record of outperformance versus the MSCI World Health Care index. In FY21 the trust posted its fourth-best year of excess return versus its benchmark in its 26-year history; this was primarily due to successful stock selection in both listed and unquoted companies.

Content on Worldwide Healthcare Trust
Worldwide Healthcare Trust – Managers optimistic about 2021 prospects
Investment companies | Review | 5 February 2021
View more
Register to receive research on Worldwide Healthcare Trust as it is published
Investment companies
Access more Investment companies content
Share price graph
Price performance
Actual (7.7) (8.5) (16.7)
Relative* (11.7) (11.8) (25.7)
52-week high/low 3960.0p/3250.0p
*% relative to local index
Key management
David Harris Chairman
Martin Smith Chairman
Sven H Borho Fund manager

You may also be interested in…